Skip to main content

Table 2 Dentists’ awareness of MRONJ and protocol followed before dental procedures

From: The awareness and practice of dentists regarding medication-related osteonecrosis of the jaw and its prevention: a cross-sectional survey

Variable

N

%

Do you record if the patient is taking anti-osteoporotic drugs?

  

Yes

969

96.9

No

31

3.1

Do you record the name of the drug and duration of its use?

  

No

187

18.7

Name only

163

16.3

Name and duration

650

65.0

Do you ask for a doctor's referral letter prior to dental surgery procedures?

  

Yes

591

59.1

No

409

40.9

How long do you advise patients to discontinue the anti-osteoporotic agent before tooth extraction or implant placement?

  

 ≤ 2 months

149

14.9

3–5 months

457

45.7

 ≥ 6 months

394

39.4

Do you recommend different drug holidays depending on the type of drug (bisphosphonates, denosumab, SERMs, PTH)?

  

Yes

467

46.7

No

533

53.3

If you have encountered case/s of MRONJ, what type of medication caused it?

  

Bisphosphonates

276

27.6

Denosumab

13

1.3

SERMs

4

0.4

No experience

707

70.7

  1. MRONJ, medication-related osteonecrosis of the jaw; SERMs, selective estrogen-receptor modulators; PTH, parathyroid hormone